(19)
(11) EP 4 262 477 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.02.2025 Bulletin 2025/09

(45) Mention of the grant of the patent:
08.01.2025 Bulletin 2025/02

(21) Application number: 21807209.8

(22) Date of filing: 25.10.2021
(51) International Patent Classification (IPC): 
A46B 15/00(2006.01)
A61C 15/04(2006.01)
A61C 17/028(2006.01)
A61C 17/36(2006.01)
 A61C 9/00(2006.01)
A61C 17/02(2006.01)
A61C 17/22(2006.01)
G06F 9/30(2018.01)
(52) Cooperative Patent Classification (CPC):
G06F 9/30032; G06F 9/3001; G06F 9/30105; G06F 9/30134; G06F 9/30141; A46B 15/0002; A46B 2200/1066; A46B 2200/108; A61C 9/0053; A61C 15/047; A61C 17/0202; A61C 17/028; A61C 17/22; A61C 17/221; A61C 17/227; A61C 17/36
(86) International application number:
PCT/GB2021/052762
(87) International publication number:
WO 2022/129841 (23.06.2022 Gazette 2022/25)

(54)

ORAL TREATMENT DEVICE

VORRICHTUNG ZUR ORALEN BEHANDLUNG

DISPOSITIF DE TRAITEMENT BUCCAL

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.12.2020 GB 202020017

(43) Date of publication of application:
25.10.2023 Bulletin 2023/43

(73) Proprietor: DYSON TECHNOLOGY LIMITED
Malmesbury Wiltshire SN16 0RP (GB)

(72) Inventor:
  • TAO, Lili
    Malmesbury Wiltshire SN16 0RP (GB)

(74) Representative: Kent, Miranda Jacket et al
Dyson Technology Limited Intellectual Property Department Tetbury Hill
Malmesbury, Wiltshire SN16 0RP
Malmesbury, Wiltshire SN16 0RP (GB)


(56) References cited: : 
WO-A1-2018/234129
WO-A2-2020/144692
US-A1- 2020 329 857
 WO-A1-2020/212248
US-A1- 2019 357 667
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).